Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road, OX3 7LD, Oxford, UK.
Cell Death Dis. 2021 Oct 20;12(11):973. doi: 10.1038/s41419-021-04258-7.
Pancreatic cancer (PC) is one of the leading causes of cancer-related death worldwide due to delayed diagnosis and limited treatments. More than 90% of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). Extensive communication between tumour cells and other cell types in the tumour microenvironment have been identified which regulate cancer hallmarks during pancreatic tumorigenesis via secretory factors and extracellular vesicles (EVs). The EV-capsuled factors not only facilitate tumour growth locally, but also enter circulation and reach distant organs to construct a pre-metastatic niche. In this review, we delineate the key factors in pancreatic ductal adenocarcinoma derived EVs that mediate different tumour processes. Also, we highlight the factors that are related to the crosstalk with cancer stem cells/cancer-initiating cells (CSC/CIC), the subpopulation of cancer cells that can efficiently metastasize and resist currently used chemotherapies. Lastly, we discuss the potential of EV-capsuled factors in early diagnosis and antitumour therapeutic strategies.
胰腺癌(PC)是全球癌症相关死亡的主要原因之一,这是由于诊断延迟和治疗手段有限所致。所有胰腺癌中超过 90%是胰腺导管腺癌(PDAC)。肿瘤细胞与肿瘤微环境中其他细胞类型之间的广泛交流已经被确定,这些交流通过分泌因子和细胞外囊泡(EVs)来调节胰腺肿瘤发生过程中的癌症特征。囊泡包裹的因子不仅促进肿瘤在局部生长,而且进入循环并到达远处器官,构建预先转移的生态位。在这篇综述中,我们描述了胰腺导管腺癌衍生的 EV 中介导不同肿瘤过程的关键因素。此外,我们还强调了与癌症干细胞/起始细胞(CSC/CIC)相互作用的因素,CSC/CIC 是能够有效转移和抵抗目前使用的化疗药物的癌细胞亚群。最后,我们讨论了 EV 包裹因子在早期诊断和抗肿瘤治疗策略中的潜力。